Back to results
US 2003/0194396 A1Published application
Antisense modulation of PTTG1 expression
AssigneesIsis Pharmaceuticals, Inc., Abbott Laboratories
InventorsAndrew T. Watt, Yan Luo
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of PTTG1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTTG1. Methods of using these compounds for modulation of PTTG1 expression and for treatment of diseases associated with expression of PTTG1 are provided.
Claims5
An antisense compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule encoding human PTTG1, wherein said antisense compound specifically hybridizes with and inhibits the expression of human PTTG1.
Dependencies are inferred from the claim text.